Marine Microorganism Fermentation Medium for Therapeutic Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer, infectious diseases, and inflammatory conditions face challenges due to drug resistance and the limited effectiveness of existing chemotherapeutic and anti-microbial agents, necessitating the discovery of new therapeutic agents.
Innovation Solution
A growth medium and salt formulation optimized for marine microorganisms, specifically containing potassium, calcium, strontium, borate, fluoride, and cobalt ions, along with the use of resins like Amberlite XAD-7, to enhance the production of marine-derived compounds such as Salinosporamide A, which have anti-cancer and anti-microbial properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chemotherapy agents are used to treat cancer, then initial therapeutic benefit is achieved, but cancer cells develop resistance and treatment effectiveness decreases
Solution Approach 1:
The patent changes the chemical parameters of the treatment by using marine-derived compounds with different molecular structures and mechanisms of action compared to conventional chemotherapy agents. These marine compounds include unique terpenes, peptides, and polyketides that interact with cancer cells through novel pathways, thereby avoiding resistance mechanisms developed against traditional drugs.
Solution Approach 2:
The patent employs composite formulations combining multiple marine-derived compounds with complementary mechanisms of action. These composite treatments target cancer cells through multiple simultaneous pathways, making it harder for cells to develop resistance and thereby extending the duration of effective treatment.
2Reliability
If existing anti-microbial agents are used to treat infectious diseases, then initial treatment success is achieved, but microorganisms develop resistance and treatment fails
Solution Approach 1:
The patent introduces marine-derived anti-microbial compounds with novel chemical structures and mechanisms that differ fundamentally from conventional antibiotics. These compounds include unique terpenes, peptides, and polyketides that target microorganisms through new pathways, thereby circumventing resistance mechanisms that have developed against traditional anti-microbial agents.
3Quantity of substance
If marine microorganisms are cultured using standard media, then basic growth is achieved, but production of desired therapeutic compounds is insufficient
Solution Approach 1:
The patent optimizes multiple parameters of the growth medium including salt concentrations (NaCl, KCl, CaCl2, MgSO4), carbon sources, nitrogen sources, pH levels, and temperature conditions. These parameter changes create optimal conditions that stimulate marine microorganisms to produce higher quantities of desired therapeutic compounds while maintaining healthy growth rates.
Solution Approach 2:
The patent uses composite growth media formulations that combine multiple nutrients, salts, and growth factors in specific ratios. These composite media provide comprehensive nourishment that triggers secondary metabolite production pathways in marine microorganisms, thereby increasing the yield of therapeutic compounds without sacrificing productivity.
4Quantity of substance
If marine microorganisms are fermented to produce therapeutic compounds, then desired compounds are generated, but undesired metabolites are also produced reducing net yield
Solution Approach 1:
The patent carefully controls fermentation parameters including pH, temperature, dissolved oxygen levels, and nutrient feed rates. These parameter changes guide the metabolic pathways of marine microorganisms toward producing desired therapeutic compounds while suppressing the formation of undesired by-products, thereby improving the ratio of desired to undesired metabolites.
Solution Approach 2:
The patent employs selective extraction techniques to isolate and remove undesired metabolites from the fermentation broth. By extracting only the desired therapeutic compounds using specific solvents or chromatographic methods, the patent effectively removes harmful by-products and concentrates the active ingredients, thereby improving net yield.
Data Source
AI summary
Growth medium are disclosed for use in fermenting a marine microorganism. The medium comprise Potassium, Calcium, Strontium, Borate and Fluoride at specific concentrations. Alternatively, the growth medium comprises cobalt at specified concentrations or comprises vitamin B12 at specified concentrations. Methods of producing certain desired compound by fermentation of a marine microorganism are also disclosed.